Bringing POTOMAC Data Into Community Urology Practice for High-Risk NMIBCByNeal D. Shore, MD, FACS,Chandler Park, MDAugust 19th 2026
POTOMAC Subgroup Data: Cystectomy Risk and Rare Adverse Events in NMIBCByNeal D. Shore, MD, FACS,Chandler Park, MDAugust 19th 2026
Managing Immune-Related Adverse Events With Durvalumab Plus BCG in NMIBCByNeal D. Shore, MD, FACS,Chandler Park, MDAugust 19th 2026
Inside the POTOMAC Trial: Durvalumab Plus BCG for High-Risk NMIBCByNeal D. Shore, MD, FACS,Chandler Park, MDAugust 19th 2026